Page last updated: 2024-10-29
indirubin-3'-monoxime and Constriction, Pathological
indirubin-3'-monoxime has been researched along with Constriction, Pathological in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Schwaiberger, AV | 1 |
Heiss, EH | 1 |
Cabaravdic, M | 1 |
Oberan, T | 1 |
Zaujec, J | 1 |
Schachner, D | 1 |
Uhrin, P | 1 |
Atanasov, AG | 1 |
Breuss, JM | 1 |
Binder, BR | 1 |
Dirsch, VM | 1 |
Other Studies
1 other study available for indirubin-3'-monoxime and Constriction, Pathological
Article | Year |
---|---|
Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
Topics: Animals; Arterial Occlusive Diseases; Becaplermin; Cell Cycle; Cell Proliferation; Cells, Cultured; | 2010 |